News results: "Genentech"

« 30 results in "Health"« 1 results in "Science"« 4 results in "Specials"
« 2 results in "Gadgets"« 2 results in "Business"
dotclear

Health

Cancer Drug Avastin Meets Endpoint In Late Stage Trial

Cancer Drug Avastin Meets Endpoint In Late Stage Trial

The outcome of the most recent study of Avastin revealed that the cancer drug is indeed effective...
» read full story November 24th, 2008 - 21:12

Avastin Raises Risk of Blood Clots

An analysis of 15 clinical trials involving Genentech’s cancer drug Avastin has found that the...
» read full story November 20th, 2008 - 16:37
Avastin Drug Linked to Blood Clots

Avastin Drug Linked to Blood Clots

Research conducted by United States scientists has revealed that the Avastin cancer drug...
» read full story November 19th, 2008 - 19:56
Avastin Linked to Blood Clot Risk, New Analysis Finds

Avastin Linked to Blood Clot Risk, New Analysis Finds

Genentech’s cancer drug Avastin was linked to a significantly increased risk of blood clots in the...
» read full story November 19th, 2008 - 14:10
Lung Cancer Treatment Drug Tarceva Makes the Disease Possible To Treat

Lung Cancer Treatment Drug Tarceva Makes the Disease Possible To Treat

The drug Tarceva, made by OSI Pharmaceuticals has been found to cause an increase in survival rates...
» read full story November 08th, 2008 - 23:55
Tarceva Slows Progress Of Lung Cancer, Study Shows

Tarceva Slows Progress Of Lung Cancer, Study Shows

After a study disclosed that the drug Tarceva was efficient in prolonging lung cancer survival when...
» read full story November 08th, 2008 - 14:33
OSI Shares Gain, Despite Preliminary Results, Tarceva Meets Its Goal

OSI Shares Gain, Despite Preliminary Results, Tarceva Meets Its Goal

Shares of OSI Pharmaceutical rose $5.25, or 15 percent, to $40.65 at 4 p.m. New York time in Nasdaq...
» read full story November 08th, 2008 - 14:30
Genentech Seeks Regulatory Approval for Avastin Use in Brain Cancer

Genentech Seeks Regulatory Approval for Avastin Use in Brain Cancer

Drug maker Genentech Inc. seeks regulatory approval for its cancer drug Avastin in patients with...
» read full story November 04th, 2008 - 15:40
Prostate Gland, a Repository of Adult Stem Cells, Genentech Researchers Found

Prostate Gland, a Repository of Adult Stem Cells, Genentech Researchers Found

Researchers at Genentech, in San Francisco, found that the prostate contains adult stem cells that...
» read full story October 23rd, 2008 - 12:11

Genentech’s Avastin reaches Phase 3

Genentech has recently announced that the study of Avastin will continue as planned, reaching phase...
» read full story October 20th, 2008 - 22:42
FDA: Genentech Psoriasis Drug Raptiva to Get Warning on Fatal Infections

FDA: Genentech Psoriasis Drug Raptiva to Get Warning on Fatal Infections

The Food and Drug Administration announced today that the label of Genentech Inc's psoriasis...
» read full story October 17th, 2008 - 14:01
Combined Treatment of Rituxan and Chemotherapy Proves Efficient in Leukemia

Combined Treatment of Rituxan and Chemotherapy Proves Efficient in Leukemia

Genentech Inc. and Biogen Idec Inc. announced that their drug Rituxan combined with chemotherapy...
» read full story October 08th, 2008 - 14:40
Tarceva-Avastin Combination Doesn’t Prolong Lung Cancer Survival

Tarceva-Avastin Combination Doesn’t Prolong Lung Cancer Survival

According to the results of a late-stage clinical trial into the benefits of combining Genentech’s...
» read full story October 07th, 2008 - 14:00
Two-Drug Combination Isn’t Up To Snuff In Lung-Cancer Trial

Two-Drug Combination Isn’t Up To Snuff In Lung-Cancer Trial

Genentech Inc. and OSI Pharmaceuticals Inc., two leading biotechnology companies, announced Monday...
» read full story October 06th, 2008 - 22:31
Update: New Breast Cancer Vaccine Proves Efficient In Lab Experiment

Update: New Breast Cancer Vaccine Proves Efficient In Lab Experiment

An experimental breast cancer vaccine proved efficient in treating breast cancer caused by an...
» read full story September 15th, 2008 - 14:45
Case of Deadly Brain Infection Prompts Labeling Revisal for Rituxan

Case of Deadly Brain Infection Prompts Labeling Revisal for Rituxan

The labeling for cancer and rheumatoid arthritis drug Rituxan is being revised after the US Food...
» read full story September 12th, 2008 - 15:38

Rituxan Treatment Associated With Brain Disorder Death

The Food and Drug Administration says that a woman passed away due to a brain infection with...
» read full story September 12th, 2008 - 15:20
Rituximab + Antibodies Makes Kidney Transplant More Feasible

Rituximab + Antibodies Makes Kidney Transplant More Feasible

A new therapy appears to improve transplant rates and outcomes for patients waiting for kidney...
» read full story July 17th, 2008 - 16:25
Invitrogen’s Genetic Test for Breast Cancer Gets FDA Clearance

Invitrogen’s Genetic Test for Breast Cancer Gets FDA Clearance

The U.S. regulators approved on Tuesday a genetic test that allows doctors to...
» read full story July 09th, 2008 - 13:09
Genentech’s Cancer Drug Avastin Questioned over Its Price

Genentech’s Cancer Drug Avastin Questioned over Its Price

Genentech’s cancer drug Avastin is now facing a halt in approval for expanded use because of its...
» read full story July 07th, 2008 - 15:51
New Data Triggers Revision of Erbitrux vs. Avastin Study

New Data Triggers Revision of Erbitrux vs. Avastin Study

While the European Medicines Agency, based in London, has approved the use of Erbitux, produced by...
» read full story June 04th, 2008 - 22:37
Erbitux Boosts Survival in Lung Cancer Patients

Erbitux Boosts Survival in Lung Cancer Patients

Results of a long awaited clinical trial of ImClone Systems Inc's Erbitux, called Flex, give hopes...
» read full story June 01st, 2008 - 08:50
EU Backs Merck KGaA’s Erbitux for First-Line Use

EU Backs Merck KGaA’s Erbitux for First-Line Use

Germany’s Merck KGaA announced Friday that Erbitux, which it licensed from ImClone System Inc and...
» read full story May 31st, 2008 - 08:20
Rituxan Fails in Lupus Trial; Shares of Genentech and Biogen Drop

Rituxan Fails in Lupus Trial; Shares of Genentech and Biogen Drop

Shares of Genentech Inc. and Biogen Idec Inc. sagged on Tuesday after the companies said their...
» read full story April 30th, 2008 - 15:38
Study: Glaxo’s Tykerb Reduces Breast Cancer-Causing Stem Cells

Study: Glaxo’s Tykerb Reduces Breast Cancer-Causing Stem Cells

GlaxoSmithKline Plc. said a new study into breast cancer-causing stem cells showed its cancer drug...
» read full story April 17th, 2008 - 16:17
New Breast Cancer Vaccine Shows Promise in Clinical Trial

New Breast Cancer Vaccine Shows Promise in Clinical Trial

A small clinical trial (conducted by the U.S. military) of an experimental vaccine designed to...
» read full story April 14th, 2008 - 11:19
Avastin’s Approval Leads to Jump in Shares for Roche

Avastin’s Approval Leads to Jump in Shares for Roche

The forecasts for Roche Holding AG saw quite a spike on Monday following the announcement that the...
» read full story February 25th, 2008 - 14:39
Avastin Approved for Breast Cancer

Avastin Approved for Breast Cancer

The Food and Drug Administration announced in December that Genentech Inc.'s drug Avastin failed to...
» read full story February 22nd, 2008 - 23:21
Cancer Drug Rituxan May Help Treat Multiple Sclerosis

Cancer Drug Rituxan May Help Treat Multiple Sclerosis

The novel cancer and rheumatoid arthritis drug Rituxan has proven to be effective when administered...
» read full story February 14th, 2008 - 18:07
Avastin Found To Be Effective In Breast Cancer Treatment

Avastin Found To Be Effective In Breast Cancer Treatment

The latest clinical trials have shown that Genentech’s cancer drug, Avastin, proved its...
» read full story February 13th, 2008 - 15:32
dotclear

Science

Avastin Drug Linked To Blood Clots

Avastin Drug Linked To Blood Clots

Research conducted by United States scientists has revealed that the Avastin cancer drug...
» read full story November 20th, 2008 - 11:00
dotclear

Specials

Study: Cancer Drug Avastin Increases Blood Cloths Risk

Study: Cancer Drug Avastin Increases Blood Cloths Risk

Avastin, Genentech’s best-selling drug, increases the risk of people developing blood clots,...
» read full story November 19th, 2008 - 16:48
Study: Lung Cancer Drug Tarceva Slows Progression of the Disease

Study: Lung Cancer Drug Tarceva Slows Progression of the Disease

Lung cancer drug Tarceva jointly developed by OSI Pharmaceuticals Inc., Genentech Inc. and Roche...
» read full story November 10th, 2008 - 15:08

FDA Warns about PML Case in Woman Taking Rituxan

A fatal case of progressive multifocal leukoencephalopathy, or PML, in a patient treated with...
» read full story September 14th, 2008 - 14:45
Genome Institute’s Renowned Director, Francis Collins, to Resign

Genome Institute’s Renowned Director, Francis Collins, to Resign

The National Human Genome Research Institute is losing one of its prestigious researchers in the...
» read full story May 29th, 2008 - 12:54
dotclear

Gadgets

iPhone Takes Second Place In Smartphone Market

iPhone Takes Second Place In Smartphone Market

Apple is already racking up blockbuster sales with consumers. The company is making small inroads...
» read full story November 09th, 2008 - 16:11
Apple Confronts RIM Head-On with Corporate Email Support

Apple Confronts RIM Head-On with Corporate Email Support

Phil Schiller, head of worldwide marketing for the maker of the iPhone, iPod and Mac line of...
» read full story March 07th, 2008 - 17:47
dotclear

Business

OSI Shares Gain After Study Shows Tarceva Meets Its Goal

OSI Shares Gain After Study Shows Tarceva Meets Its Goal

Shares of OSI Pharmaceutical rose $5.25, or 15 percent, to $40.65 at 4 p.m. New York time in Nasdaq...
» read full story November 10th, 2008 - 06:58
Canalys: BlackBerry Overtaken By The iPhone In The Third Quarter

Canalys: BlackBerry Overtaken By The iPhone In The Third Quarter

Apple’s new iPhone appears to be winning ground on the U.S. corporate market, which up until...
» read full story November 08th, 2008 - 09:39
dotclear
dotclear
dotclear
Photos Gallery
dotclear